Advances in multiparameter optimization methods for de novo drug design

Area of Science:

• Medicinal Chemistry
• Computational Drug Discovery
• Pharmacology

Background:

• Achieving optimal drug properties requires balancing physicochemical, ADME, safety, and potency factors.
• Multiparameter optimization (MPO) guides simultaneous optimization of multiple drug characteristics.
• MPO combined with de novo design accelerates the identification of successful drug candidates.

Purpose of the Study:

• To review multiparameter optimization (MPO) methods in drug discovery.
• To describe advances in de novo design for generating relevant compound structures.
• To integrate MPO with de novo design for property optimization.

Main Methods:

• Review of MPO methodologies and recent field developments.
• Description of de novo design advancements for structure generation and MPO integration.
• Case study analysis of automatic ligand design for polypharmacological profiles.

Main Results:

• Recent de novo design methods reduce chemically infeasible structures.
• Improved quality and relevance of automatically generated compounds.
• Successful integration of MPO with de novo design strategies.

Conclusions:

• De novo design methods enhance the identification of high-quality drug candidates.
• Concerns remain regarding simple property indices for detailed compound optimization.
• Expert scientists can leverage de novo design outputs for informed synthesis decisions.